KAWASAKI DISEASE
Clinical trials for KAWASAKI DISEASE explained in plain language.
Never miss a new study
Get alerted when new KAWASAKI DISEASE trials appear
Sign up with your email to follow new studies for KAWASAKI DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to shield Kids' hearts from kawasaki damage
Disease control CompletedThis small pilot study tested two drugs—atorvastatin and anakinra—in 5 children with Kawasaki disease who had coronary artery abnormalities. The goal was to see if the combination is safe and can reduce artery inflammation to prevent future heart problems. The study focused on sa…
Matched conditions: KAWASAKI DISEASE
Phase: EARLY_PHASE1 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Steroid combo may shield kids' hearts from kawasaki damage
Disease control CompletedThis study looked at whether adding a steroid called prednisolone to the usual treatment (immunoglobulin and aspirin) could reduce damage to the heart's arteries in children with Kawasaki disease. Over 3,200 children were enrolled. The main goal was to see if fewer children devel…
Matched conditions: KAWASAKI DISEASE
Phase: PHASE3 • Sponsor: Children's Hospital of Fudan University • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
Kawasaki Kids' hearts checked 5 years later
Knowledge-focused CompletedThis study looked at the heart and blood vessel health of 61 children who had Kawasaki disease 5 years earlier and were treated with IVIG. Researchers compared them to healthy children using blood tests, blood pressure, artery stiffness, and heart imaging. The goal was to find ea…
Matched conditions: KAWASAKI DISEASE
Sponsor: Medical University of Warsaw • Aim: Knowledge-focused
Last updated May 12, 2026 13:40 UTC